DOI: 10.1128/CVI.00662-13
Article Information
PubMed
Published By
History
- Received October 17, 2013
- Returned for modification November 8, 2013
- Accepted November 29, 2013
- Published online January 29, 2014.
Copyright & Usage
Copyright © 2014, American Society for Microbiology. All Rights Reserved. The authors have paid a fee to allow immediate free access to this article.
Editors and / or Reviewers
- D. L. Burns, Editor
Article Versions
- Accepted Manuscript version (December 11, 2013).
- You are viewing the most recent version of this article.
Author Information
- Marc Kirchmeiera,
- Anne-Catherine Fluckigerb,
- Catalina Soarea,
- Jasminka Bozica,
- Barthelemy Ontsoukaa,
- Tanvir Ahmeda,
- Abebaw Diressa,
- Lenore Pereirac,
- Florian Schödeld,
- Stanley Plotkine,
- Charlotte Dalbaa,
- David Klatzmannf,g,h,i and
- David E. Andersona
- aVBI Vaccines, Cambridge, Massachusetts, USA
- bBionaria, Saint-Genis-les-Ollières, France
- cUniversity of California San Francisco, San Francisco, California, USA
- dPhilimmune LLC, Philadelphia, Pennsylvania, USA
- eUniversity of Pennsylvania, Philadelphia, Pennsylvania, USA
- fUPMC University, Paris, France
- gCNRS, Paris, France
- hINSERM, Paris, France
- iHôpital Pitié-Salpêtrière, Paris, France
- Address correspondence to David E. Anderson, danderson{at}vbivaccines.com.
Article usage
Enveloped Virus-Like Particle Expression of Human Cytomegalovirus Glycoprotein B Antigen Induces Antibodies with Potent and Broad Neutralizing Activity
